Zobrazeno 1 - 10
of 74
pro vyhledávání: '"RAAS blockers"'
Autor:
Yu-qiong Lin, Feng Yu, Hui-jun Chen, Yuan-rong Deng, Jin Lin, Ying Xu, Xin Zheng, Jing-wen Zhang, Jun-feng Liu
Publikováno v:
Renal Failure, Vol 46, Iss 2 (2024)
Objective To determine the efficacy and safety of Astragalus combined with renin-angiotensin-aldosterone system (RAAS) blockers in treating stage III diabetic nephropathy (DN) by meta-analysis.Methods PubMed, Embase, Cochrane Library, Wiley, and Web
Externí odkaz:
https://doaj.org/article/750e3242df5e486dbc914d905798e3e7
Autor:
Nestor Vazquez-Agra, Ana-Teresa Marques-Afonso, Anton Cruces-Sande, Estefania Mendez-Alvarez, Ramon Soto-Otero, Jose-Enrique Lopez-Paz, Antonio Pose-Reino, Alvaro Hermida-Ameijeiras
Publikováno v:
Antioxidants, Vol 12, Iss 4, p 802 (2023)
As in other fields, chronotherapy applied to arterial hypertension (AHT) may have implications on oxidative stress. We compared the levels of some redox markers between hypertensive patients with morning and bedtime use of renin-angiotensin-aldostero
Externí odkaz:
https://doaj.org/article/efc2c862c1624a0d9caea5fe2f4246ee
Autor:
Chaoran Wu, Guangbo Qu, Lei Wang, Shiyu Cao, Dandan Xia, Baolong Wang, Xiaoyun Fan, Changhui Wang
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Coronavirus disease (COVID-19) patients with cardiovascular and metabolic disorders have been found to have a high risk of developing severe conditions with high mortality, further affecting the prognosis of COVID-19. However, the effect of hypertens
Externí odkaz:
https://doaj.org/article/6581e4b43b3844ee93af29bb1fc79b87
Autor:
E. V. Sayutina
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 17, Iss 6, Pp 86-94 (2018)
Modern appropriate treatment of hypertension involves the use of combination antihypertensive therapy. According to updated version of European Society of Cardiology 2018 guidelines, renin-angiotensin-aldosterone system blockers must be used as first
Externí odkaz:
https://doaj.org/article/36d8788cd9de49bcab345325c02063c9
Autor:
Simon B. Gressens, Georges Leftheriotis, Jean-Claude Dussaule, Martin Flamant, Bernard I. Levy, Emmanuelle Vidal-Petiot
Publikováno v:
Frontiers in Physiology, Vol 12 (2021)
Since December 2019, the coronavirus 2019 (COVID-19) pandemic has rapidly spread and overwhelmed healthcare systems worldwide, urging physicians to understand how to manage this novel infection. Early in the pandemic, more severe forms of COVID-19 ha
Externí odkaz:
https://doaj.org/article/829e780ea95c45a8a5868deee785e32c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Počki, Vol 7, Iss 4, Pp 238-244 (2018)
Renoprotection is a system of measures for primarily pharmacological control, contributing to the continued preservation of renal function. When choosing renoprotection tactics, it is necessary to consider not only the estimated GFR (using the EPI fo
Externí odkaz:
https://doaj.org/article/dc160755d2de4480b985db5df11d3a5c
Publikováno v:
Медицинский совет, Vol 0, Iss 20, Pp 40-44 (2018)
The study included 75 women with arterial hypertension, aged 48-51 years (Me 50,0 years [25%; 75%: 48,0; 52,0 years]), who according to the clinical laboratory and instrumental examination was diagnosed essential hypertension (EH) I–II stage of 1
Externí odkaz:
https://doaj.org/article/f21ea8e5bbdd4bcd900bb6839758362e
Background:We aim to investigate the impact of hydration status (12-hour fasting or 12-hour water-free fasting) on the estimated glomerular filtration rate (eGFR) and serum potassium in renin-angiotensin-aldosterone (RAAS) blocker users during bioche
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fe50d8c3e802004aa0a8401e6ba9395
